Dealing With Drug Prices | KHN's 'What the Health?'

Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.

Event Date: Thursday, January 13, 2022

Event Webpage (Available for subscribers only)

Category(s): Health Policy and Regulatory, Pharmaceutical

Contact Speaker / Organization (Available for subscribers only)